Citi Upgrades EnCana To Buy Ahead Of Analyst Day

While Encana Corp’s ECA debt metrics have improved, the overhang of an equity offering is now behind the company, Citi’s Robert S Morris said in a report. He upgraded the rating on Encana from Neutral to Buy, while raising the price target from $10 to $13.

EnCana is scheduled to host its Analyst Meeting on October 5. “We expect an extensive operational update, full-scale development plans for the Permian Basin and slight revision to the timing of Montney liquids production reaching 50 MBbls/d post the Gordondale sale, i.e. now YE’18,” analyst Morris wrote. He added that the company may provide more details of its 5-year plan for its Top-Four plays.

Strong Liquids Growth

Morris expects EnCana’s total organic production to grow at a CAGR of ~12 percent from 2016 through 2021, while organic oil/liquid volumes growing at a CAGR of ~20 percent. The growth would likely be “largely driven by the Permian and Montney with ECA's 'Top Four' output (~70% of current total) doubling while the total production mix transitions to ~48% from ~35% liquids in 2021.”

Debt-Adjusted Per-Share Growth Metrics

The analyst projected an increase of ~88 percent in EnCana's CF/DAS in 2016, versus an average increase of ~57 percent for oil-leveraged large-cap E&P peers. He added that the equity offering removed EnCana from the list of companies with weak balance sheets and would likely enable the company to maintain its investment grade credit rating.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorLong IdeasUpgradesPrice TargetAnalyst RatingsTrading IdeasCitiRobert S Morris
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!